Literature DB >> 2426307

Hypobetalipoproteinemia with accumulation of an apoprotein B-like protein in intestinal cells. Immunoenzymatic and biochemical characterization of seven cases of Anderson's disease.

M E Bouma, I Beucler, L P Aggerbeck, R Infante, J Schmitz.   

Abstract

We describe here seven cases (from five kindreds) of Anderson's disease, which is characterized by diarrhea, steatorrhea, hypobetalipoproteinemia with low levels of cholesterol, triglycerides, and phospholipids, and failure to secrete chylomicrons after a fat meal. Enterocytes isolated from intestinal biopsies of patients after overnight fast showed numerous fat droplets, a histological picture resembling that of abetalipoproteinemia. Immunoenzymatic staining of the enterocytes demonstrated large amounts of material that reacted with a polyclonal antiserum to apolipoprotein B. Further, the immunoreactive material was found to react with several different monoclonal antibodies capable of recognizing both the B100 and B48 forms of apoprotein B, but not with any of several monoclonal antibodies capable of recognizing only B100. This suggests that the material in the enterocytes is the B48 form of apoprotein B or a fragment thereof. Additional findings included decreased low density lipoprotein levels with an abnormal chemical composition, abnormal high density lipoprotein2 (HDL2) and HDL3 particle size distributions, and an abnormal HDL apoprotein composition. Increased amounts of proteins having electrophoretic mobilities similar to apo E and the E-AII complex were present. Finally, some cases exhibited additional protein components of apparent molecular weights between 17,000 and 28,000, which was similar to some cases of abetalipoproteinemia. These findings demonstrate that Anderson's disease is not due to the absence of synthesis of intestinal apo B and suggest that it is more complex than previously thought, affecting all the lipoprotein classes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426307      PMCID: PMC423563          DOI: 10.1172/JCI112590

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  CYTOCHEMICAL DEMONSTRATION OF PEROXIDASE ACTIVITY WITH 3-AMINO-9-ETHYLCARBAZOLE.

Authors:  R C GRAHAM; U LUNDHOLM; M J KARNOVSKY
Journal:  J Histochem Cytochem       Date:  1965-02       Impact factor: 2.479

2.  Localization of apolipoprotein B in intestinal epithelial cells.

Authors:  R M Glickman; J Khorana; A Kilgore
Journal:  Science       Date:  1976-09-24       Impact factor: 47.728

3.  A new enzymatic method for determination of serum choline-containing phospholipids.

Authors:  M Takayama; S Itoh; T Nagasaki; I Tanimizu
Journal:  Clin Chim Acta       Date:  1977-08-15       Impact factor: 3.786

4.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

5.  Intestinal epithelial cell surface membrane glycoprotein synthesis. I. An indicator of cellular differentiation.

Authors:  M M Weiser
Journal:  J Biol Chem       Date:  1973-04-10       Impact factor: 5.157

6.  [Anderson's disease].

Authors:  C Polonovski; J Navarro; J L Fontaine; F de Gouyon; J M Saudubray; L Cathelineau
Journal:  Ann Pediatr (Paris)       Date:  1970-05-02

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  The lattice spacing of crystalline catalase as an internal standard of length in electron microscopy.

Authors:  N G Wrigley
Journal:  J Ultrastruct Res       Date:  1968-09

9.  Studies of the proteins in human plasma very low density lipoproteins.

Authors:  W V Brown; R I Levy; D S Fredrickson
Journal:  J Biol Chem       Date:  1969-10-25       Impact factor: 5.157

10.  A study of the abnormal lipoproteins in abetalipoproteinemia.

Authors:  A M Scanu; L P Aggerbeck; A W Kruski; C T Lim; H J Kayden
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

View more
  11 in total

Review 1.  The biogenesis of chylomicrons.

Authors:  Charles M Mansbach; Shadab A Siddiqi
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

2.  Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease.

Authors:  Charlotte Cuerq; Emilie Henin; Lioara Restier; Emilie Blond; Jocelyne Drai; Christophe Marçais; Mathilde Di Filippo; Christian Laveille; Marie-Caroline Michalski; Pierre Poinsot; Cyrielle Caussy; Agnès Sassolas; Philippe Moulin; Emmanuelle Reboul; Sybil Charriere; Emile Levy; Alain Lachaux; Noël Peretti
Journal:  J Lipid Res       Date:  2018-07-18       Impact factor: 5.922

3.  Biosynthetic precursor (214 kDa) of apolipoprotein B-48 is not secreted by Caco-2 cells and normal human intestine.

Authors:  W V Sasak; H A Buller; R Reinhold
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

Review 4.  Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.

Authors:  Sebastiano Calandra; Patrizia Tarugi; Helen E Speedy; Andrew F Dean; Stefano Bertolini; Carol C Shoulders
Journal:  J Lipid Res       Date:  2011-08-23       Impact factor: 5.922

Review 5.  Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers.

Authors:  Noel Peretti; Agnès Sassolas; Claude C Roy; Colette Deslandres; Mathilde Charcosset; Justine Castagnetti; Laurence Pugnet-Chardon; Philippe Moulin; Sylvie Labarge; Lise Bouthillier; Alain Lachaux; Emile Levy
Journal:  Orphanet J Rare Dis       Date:  2010-09-29       Impact factor: 4.123

6.  Anderson's disease: genetic exclusion of the apolipoprotein-B gene in two families.

Authors:  M Pessah; P Benlian; I Beucler; N Loux; J Schmitz; C Junien; R Infante
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

Review 7.  Diagnosis and management of familial dyslipoproteinemias.

Authors:  Peter O Kwiterovich
Journal:  Curr Cardiol Rep       Date:  2013-06       Impact factor: 2.931

8.  Rat intestinal apolipoprotein B gene expression. Evidence for integrated regulation by bile salt, fatty acid, and phospholipid flux.

Authors:  N O Davidson; M J Drewek; J I Gordon; J Elovson
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

9.  Decreased expression of Intestinal I- and L-FABP levels in rare human genetic lipid malabsorption syndromes.

Authors:  S Guilmeau; I Niot; J P Laigneau; H Devaud; V Petit; N Brousse; R Bouvier; L Ferkdadji; C Besmond; L P Aggerbeck; A Bado; M E Samson-Bouma
Journal:  Histochem Cell Biol       Date:  2007-06-29       Impact factor: 4.304

10.  Exon skipping of hepatic APOB pre-mRNA with splice-switching oligonucleotides reduces LDL cholesterol in vivo.

Authors:  Petra Disterer; Raya Al-Shawi; Stephan Ellmerich; Simon N Waddington; James S Owen; J Paul Simons; Bernard Khoo
Journal:  Mol Ther       Date:  2013-01-15       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.